Genetics and genomics of infectious disease susceptibility

British Medical Bulletin

Volumn 55, Issue 2, 1999, Pages 401-413

  Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENETICS; IMMUNOMODULATION; INFECTION; MALARIA; MYCOBACTERIOSIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VACCINATION;

CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; INFECTION; VACCINES, SYNTHETIC;

EID: 0032858072     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902457     Document Type: Review

References (62)

1. Harboe M. Gerhard Henrik Armauer Hansen - still of current interest. Tidsskr Nor Laegeforen 1992; 112: 3795-8
2. Flanders WD, Khoury MJ. Analysis of case-parental control studies: method for the study of associations between disease and genetic markers. Am J Epidemiol 1996; 144: 696-703
3. Haldane JBS. Disease and evolution. La Ricercha Scientifica 1949; 19 Suppl: 68-76
4. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 1988; 8: 4518-23
5. Weeks DE, Lathrop GM. Polygenic disease: methods for mapping complex disease traits. Trends Genet 1995; 11: 513-9
6. McLeod R, Buschman E, Arbuckle LD, Skamene E. Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Opin Immunol 1995; 7: 539-52
7. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for BCG. Cell 1993; 73: 469-85
8. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AVS. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-4
9. Chakravarti MR, Vogel F. A twin study on leprosy. Top Hum Genet 1973; 1: 1-123
10. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978; 117: 621-4
11. de Vries RR, Fat RF, Nijenhuis LE, van Rood JJ. HLA-linked genetic control of host response to Mycobacterium leprae. Lancet 1976; ii: 1328-30
12. Singh SP, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-81
13. Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens 1993; 42: 133-7
14. Brahmajothi V, Pitchappan RM, Kakkanaiah VN et al.. Association of pulmonary tuberculosis and HLA in south India. Tubercle 1991; 72: 123-32
15. Todd JR, West BC, McDonald JC. Human leukocyte antigen and leprosy: study in northern Louisiana and review. Rev Infect Dis 1990; 12: 63-74
16. Bothamley GH, Beck JS, Schreuder GM, de Vries RR, Kardjito T, Ivanyi J. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis 1989; 159: 549-55
17. Roy S, McGuire W, Mascie-Taylor CG et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176: 530-2
18. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-9
19. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guèrin infection. N Engl J Med 1996; 335: 1956-61
20. Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-5
21. Jong R, Altare F, Haagen IA et al. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435-8
22. James SP, Nicol WD, Shute PG. A study of induced malignant tertian malaria. Proc R Soc Med 1932; 25: 1153-86
23. Allison AC. Protection afforded by sickle-cell trait against subtertain malarial infection. BMJ 1954; i: 290-4
24. Allison AC. Polymorphism and natural selection in human populations. Cold Spring Harb Symp Quant Biol 1964; 29: 137-49
25. Ruwende C, Khoo SC, Snow RW et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-9
26. Willcox M, Bjorkman A, Brohult J, Pehrson PO, Rombo L, Bengtsson E. A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassaemia traits. Ann Trop Med Parasitol 1983; 77: 239-46
27. Allen SJ, O'Donnell A, Alexander ND et al. Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997; 94: 14736-41
28. Williams TN, Maitland K, Bennett S et al. High incidence of malaria in alpha-thalassaemic children. Nature 1996; 383: 522-5
29. Modiano D, Petrarca V, Sirima BS et al. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc Natl Acad Sci USA 1996; 93: 13206-11
30. Hill AV, Allsopp CE, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600
31. Hill AVS, Yates SN, Allsopp CE et al. Human leukocyte antigens and natural selection by malaria. Philos Trans R Soc Lond B Biol Sci 1994; 346: 379-85
32. Hill AVS, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434-9
33. Gilbert SC, Plebanski M, Gupta S et al. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 1998; 279: 1173-7
34. Fernandez-Reyes D, Craig AG, Kyes SA et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997; 6: 1357-60
35. Fowke KR, Nagelkerke NJ, Kimani J et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348: 1347-51
36. Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera NB, Moroni M, Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 1986; ii: 1187-9
37. Kaslow RA, Duquesnoy R, VanRaden M et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 1990; 335: 927-30
38. McNeil AJ, Yap PL, Gore SM et al. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM 1996; 89: 177-85
39. Kaslow RA, Carrington M, Apple R et al. Influence of combinations of major histocompatibility genes on the course of HIV-1 infection. Nat Med 1996; 2: 405-11
40. Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS 1995; 9: 275-80
41. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-62
42. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-65
43. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-93
44. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-40
45. Deslys J-P, Jaeglyy A, d'Aignaux JH, Mouthon F, Billette de Villemeur T, Dormont D. Genotype at codon 129 and susceptibility to Creutzfeldt-Jacob disease. Lancet 1998; 351: 1251
46. Brown P, Cervenakova L, Goldfarb LG et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994; 44: 291-3
47. Marquet S, Abel L, Hillaire D et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996; 14: 181-4
48. Pier GB, Grout M, Zaidi T et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998; 393: 79-82
49. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9
50. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-10
51. Kwiatkowski D, Molyneux ME, Stephens S et al. Anti-TNF therapy inhibits fever in cerebral malaria. QJM 1993; 86: 91-8
52. van Hensbroek MB, Palmer A, Onyiorah E et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 1996; 174: 1091-7
53. Bellamy R, Ruwende C, McAdam KP et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM 1998; 91: 13-8
54. Daniels SE, Bhattacharrya S, James A et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-50
55. Davenport M, Hill AVS. Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol Med Today 1996; 2: 38-45
56. Davenport MP, Ho Shon IA, Hill AV. An empirical method for the prediction of T-cell epitopes. Immunogenetics 1995; 42: 392-7
57. Hoffman SL, Franke ED. Inducing protective immune responses against the sporozoite and liver stages of Plasmodium. Immunol Lett 1994; 41: 89-94
58. Schneider J, Gilbert SC, Blanchard TJ et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Mat Med 1998; 4: 397-402
59. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593-617
60. Davenport MP, Quinn CL, Chicz RM et al. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci USA 1995; 92: 6567-71
61. Kostrikis LG, Huang Y, Moore JP et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998; 4: 350-3
62. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7